With the exception of the novel loci identified in our investigation, subsequent GO and KEGG pathway analyses of the remaining significant loci related to ApoA1 and ApoB/ApoA1 showed a dyslipidemia-related function (Figure S2 and Table S4). This evidence concerns the gene APOA1 and metabolic syndrome.